GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Aceso Life Science Group Ltd (HKSE:00474) » Definitions » Asset Turnover

Aceso Life Science Group (HKSE:00474) Asset Turnover : 0.02 (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Aceso Life Science Group Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Aceso Life Science Group's Revenue for the six months ended in Sep. 2023 was HK$113.0 Mil. Aceso Life Science Group's Total Assets for the quarter that ended in Sep. 2023 was HK$5,801.0 Mil. Therefore, Aceso Life Science Group's Asset Turnover for the quarter that ended in Sep. 2023 was 0.02.

Asset Turnover is linked to ROE % through Du Pont Formula. Aceso Life Science Group's annualized ROE % for the quarter that ended in Sep. 2023 was -29.35%. It is also linked to ROA % through Du Pont Formula. Aceso Life Science Group's annualized ROA % for the quarter that ended in Sep. 2023 was -7.14%.


Aceso Life Science Group Asset Turnover Historical Data

The historical data trend for Aceso Life Science Group's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceso Life Science Group Asset Turnover Chart

Aceso Life Science Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.06 0.06 0.05 0.05

Aceso Life Science Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.03 0.03 0.02

Competitive Comparison of Aceso Life Science Group's Asset Turnover

For the Conglomerates subindustry, Aceso Life Science Group's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aceso Life Science Group's Asset Turnover Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Aceso Life Science Group's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Aceso Life Science Group's Asset Turnover falls into.



Aceso Life Science Group Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Aceso Life Science Group's Asset Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=312/( (6301+6301)/ 2 )
=312/6301
=0.05

Aceso Life Science Group's Asset Turnover for the quarter that ended in Sep. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=113/( (6301+5301)/ 2 )
=113/5801
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Aceso Life Science Group  (HKSE:00474) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Aceso Life Science Group's annulized ROE % for the quarter that ended in Sep. 2023 is

ROE %**(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-414/1410.5
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-414 / 226)*(226 / 5801)*(5801/ 1410.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=-183.19 %*0.039*4.1127
=ROA %*Equity Multiplier
=-7.14 %*4.1127
=-29.35 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Aceso Life Science Group's annulized ROA % for the quarter that ended in Sep. 2023 is

ROA %(Q: Sep. 2023 )
=Net Income/Total Assets
=-414/5801
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-414 / 226)*(226 / 5801)
=Net Margin %*Asset Turnover
=-183.19 %*0.039
=-7.14 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Aceso Life Science Group Asset Turnover Related Terms

Thank you for viewing the detailed overview of Aceso Life Science Group's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Aceso Life Science Group (HKSE:00474) Business Description

Traded in Other Exchanges
N/A
Address
6 - 8 Harbour Road, Rooms 2501 - 2509, 25th Floor, Shui On Centre, Wanchai, Hong Kong, HKG
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending; Rental and sale of construction machinery and spare parts business; Provision of repair and maintenance and transportation service business; Provision of asset management, securities brokerage, commodities, futures and other financial service business; Property leasing business; and Property development business. It derives key revenue from the rental and sale of construction machinery and spare part. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau and Cambodia.
Executives
Li Shao Yu 2101 Beneficial owner
Asia Link Capital Investment Holdings Limited 2201 Interest of corporation controlled by you
Haitong International Holdings Limited
Huang Tao 2201 Interest of corporation controlled by you
Huang Shiying 2201 Interest of corporation controlled by you
Century Golden Resources Investment Co., Ltd 2101 Beneficial owner
Haitong International Securities Group (singapore) Pte. Ltd.
Haitong International Financial Products (singapore) Pte. Ltd.
Haitong Securities Co., Ltd.
Haitong International Securities Group Limited
Atlantis Capital Group Holdings Limited
Co-high Investment Management Limited
Liu Yang
Dong Zimeng
East Jumbo Development Limited 2501 Other

Aceso Life Science Group (HKSE:00474) Headlines

No Headlines